- Tumour microenvironment
- Neurotransmitters in Cancer
- GABA and GABA receptors
Accepting applications from PhD students.
Dr Bogdanov was appointed as Lecturer in Transgenic Technologies in 2015.
Dr Bogdanov graduated from Kharkov National University in 1991 majoring in genetics. He then moved to Engelhardt Institute of Molecular Biology where he completed his PhD in molecular biology in 1995. After completing his PhD he worked at the University College London on ATP receptors and calcium channels and then at University of Pennsylvania to work on GABA receptor biology. Dr Bogdanov is an expert in neuroscience, molecular biology and genetically modified animals.
Dr Bogdanov is interested in two main areas – modulating GABAergic signaling in the immune system to augment immunotherapy of solid tumors and developing new animal models for cancer research.